EirGenix Inc. announced the establishment of the company's Corporate Governance Committee with Lee-Cheng Liu: President & CEO, EirGenix, Inc; Ming-Thaur Chang: Independent Director, DBS Bank (Taiwan) Ltd.; Fu-Shiow Yin: Independent Director, Foresee Pharmaceuticals Co. Ltd.; Ming-Shen Chen: Professor of Finance at National Taiwan University.; and Po-Chih Chen: Senior Advisors to the President, effective December 28, 2022. Mr. Ming-Shen Chen is the chairman of first term Corporate Governance Committee.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
80 TWD | +0.88% | 0.00% | -20.40% |
05-15 | EirGenix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-22 | EirGenix Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.40% | 750M | |
-0.28% | 90.59B | |
0.00% | 38.99B | |
-8.52% | 34.09B | |
+64.13% | 26.38B | |
-17.37% | 15.02B | |
-5.99% | 13.17B | |
-10.69% | 11.88B | |
-47.78% | 10.65B | |
+8.09% | 9.25B |
- Stock Market
- Equities
- 6589 Stock
- News EirGenix Inc.
- Eirgenix Inc. Announces Establishment of Corporate Governance Committee